Archives of medical sciences. Atherosclerotic diseases · 2025
Cortisol as a factor contributing to the development of non-alcoholic fatty liver disease in severely obese patients: a single-center prospective study.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Constantinopoulos Petros, Georgoulia Georgia, Theofanis George, Antzoulas Andreas, Litsas Dimitrios, Papadopoulos Panagiotis Dimitrios, Liolis Elias, Leventis Panagiotis, Kornaros Nikolaos, Leivaditis Vasileios, Mulita Francesk, Skroubis George
Аннотация
INTRODUCTION: Nonalcoholic fatty liver disease (NAFLD) is known to have high prevalence in obese patients, and has been found to be associated with the metabolic syndrome (MetS). This study aimed to investigate possible correlations of NAFLD with hypothalamic-pituitary-adrenal (HPA) axis activity and expression levels of hydroxysteroid (11-beta) dehydrogenase 1 (HSD11B1), nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptors) a (NR3C1a) and b (NR3C1b) in the liver, visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT).
MATERIAL AND METHODS: In this single-center study, 34 severely obese patients (BMI > 40 kg/m2), scheduled to undergo bariatric surgery, were recruited and enrolled prospectively. Before the day of surgery, urinary free cortisol (UFC) and diurnal variation of serum and salivary cortisol were estimated. During surgery, biopsies of the liver, VAT, and SAT were obtained.
RESULTS: The expression of the visceral adipose tissue HSD11B1 (VAT HSD11B1) was significantly higher in the groups of patients with NAFLD (NAFLD+) or NASH (NASH+), compared with those without (NAFLD-, NASH-). The expression of NR3C1a in the liver (LNR3C1a) was significantly lower in the NAFLD+ group compared with the NAFLD- group. In the NAFLD group, the expression of HSD11B1 in the liver (LHSD11B1) exhibited a negative correlation with LNR3C1a, whereas no association was found in the NAFLD+ group.
CONCLUSIONS: The activity of the HPA axis, and tissue and systemic cortisol levels, contribute to MetS development. There are similarities between MetS and NAFLD concerning their pathophysiological mechanisms.
MATERIAL AND METHODS: In this single-center study, 34 severely obese patients (BMI > 40 kg/m2), scheduled to undergo bariatric surgery, were recruited and enrolled prospectively. Before the day of surgery, urinary free cortisol (UFC) and diurnal variation of serum and salivary cortisol were estimated. During surgery, biopsies of the liver, VAT, and SAT were obtained.
RESULTS: The expression of the visceral adipose tissue HSD11B1 (VAT HSD11B1) was significantly higher in the groups of patients with NAFLD (NAFLD+) or NASH (NASH+), compared with those without (NAFLD-, NASH-). The expression of NR3C1a in the liver (LNR3C1a) was significantly lower in the NAFLD+ group compared with the NAFLD- group. In the NAFLD group, the expression of HSD11B1 in the liver (LHSD11B1) exhibited a negative correlation with LNR3C1a, whereas no association was found in the NAFLD+ group.
CONCLUSIONS: The activity of the HPA axis, and tissue and systemic cortisol levels, contribute to MetS development. There are similarities between MetS and NAFLD concerning their pathophysiological mechanisms.